« Back to Record
Citation APA

Awada, A., Cardoso, F., Fontaine, C., Dirix, L. Y., De Greve, J., Sotiriou, C., Steinseifer, J., Wouters, C., Tanaka, C., Zoellner, U., Tang, P., & Piccart-Gebhart, M. (2008). The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics. European journal of cancer, 44(1), 84-91. doi:10.1016/j.ejca.2007.10.003


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53821

Awada, A., Cardoso, F., Fontaine, C., Dirix, L. Y., De Greve, J., Sotiriou, C., Steinseifer, J., Wouters, C., Tanaka, C., Zoellner, U., Tang, P., & Piccart-Gebhart, M. (2008). The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics. European journal of cancer, 44(1), 84-91. doi:10.1016/j.ejca.2007.10.003